Loading...

PE/Cyanine7 anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_PECy7_122607
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE/Cyanine7
  • BM8_PECy7_122607
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
123113 25 µg £72
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123114 100 µg £208
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  2. Orberg E, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.53. PubMed
  3. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  4. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  5. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  6. Fan G, et al. 2021. Cell Death Dis. 12:73. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  9. Aggen DH, et al. 2020. Clin Cancer Res. . PubMed
  10. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  11. Lauterbach MA, et al. 2020. Immunity. 51(6):997-1011.e7.. PubMed
  12. Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed
  13. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  14. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  15. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  16. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  17. Dando SJ, et al. 2021. Invest Ophthalmol Vis Sci. 62:10. PubMed
  18. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  19. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  20. Saxena A, et al. 2013. J Immunol. 191:4838. PubMed
  21. Giordano C, et al. 2014. Hum Mol Genet. . PubMed
  22. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  23. Sadek J, et al. 2021. EMBO Mol Med. 13:e13591. PubMed
  24. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
  25. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  26. Kesavan R, et al. 2021. Int J Mol Sci. 22:. PubMed
  27. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  28. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  29. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
  30. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  31. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  32. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  33. Shikatani EA et al. 2019. Cell Rep. 27(8):2304-2312 . PubMed
  34. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  35. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  36. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  37. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  38. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  39. Patnode M, et al. 2013. J Biol Chem. 288:26533. PubMed
  40. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  41. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  42. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  43. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  44. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  45. Sive J, et al. 2015. Leukemia. . PubMed
  46. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  47. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  48. Koh EH, et al. 2018. Diabetes. 67(12). PubMed
  49. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  50. Shimoda A, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.126. PubMed
  51. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  52. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  53. Jondle C, et al. 2016. J Immunol. 196: 3088-3096. PubMed
  54. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  55. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  56. Zhang S, et al. 2019. Cell Metab. 29:443. PubMed
  57. Qu J, et al. 2018. J Immunol Res. 2018:7519856. PubMed
  58. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  59. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  60. Wu X, et al. 2021. Elife. 10:. PubMed
  61. Roy R, et al. 2022. Elife. 11:. PubMed
  62. Tay S, et al. 2014. J Immunol. 193:2087. PubMed
  63. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  64. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  65. Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
  66. Tomlinson KL, et al. 2021. Nat Commun. 12:1399. PubMed
  67. Wu MY, et al. 2021. Autophagy. 17:1096. PubMed
  68. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  69. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  70. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  71. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  72. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  73. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  74. Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed
  75. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  76. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  77. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  78. Ganguly K, et al. 2022. Front Immunol. 13:930449. PubMed
  79. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  80. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  81. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  82. Mojumdar K, et al. 2014. EMBO Mol Med. 6:1476. PubMed
  83. Torroella-Kouri M, et al. 2009. Cancer Res. 69:4800. PubMed
  84. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  85. Xu X, et al. 2018. Cell. 175:1336. PubMed
  86. Oertel S, et al. 2017. Cell Mol Life Sci. 10.1007/s00018-017-2518-9. PubMed
  87. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  88. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  89. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  90. Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed
  91. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  92. Chiu Y, et al. 2014. J Immunol. 193:2207. PubMed
  93. Hamilton J, et al. 2015. J Immunol. 194:5022. PubMed
  94. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  95. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  96. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  97. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  98. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  99. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  100. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  101. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  102. Xiong X et al. 2019. Mol Cell. 75(3):644-660 . PubMed
  103. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  104. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  105. Park HB, et al. 2020. Nat Microbiol. 1319:5. PubMed
  106. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  107. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  108. Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed
  109. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  110. Maisel D, et al. 2016. PLoS One. 11: 0159716. PubMed
  111. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  112. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  113. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  114. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  115. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  116. Sun P, et al. 2022. Nat Commun. 13:6562. PubMed
  117. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  118. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  119. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  120. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  121. Ahn D, et al. 2021. Cell Reports. 35(9):109196. PubMed
  122. Efremova M, et al. 2018. Nat Commun. 9:32. PubMed
  123. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  124. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  125. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  126. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  127. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  128. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  129. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  130. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  131. Sharif O, et al. 2013. J Immunol. 190:5640. PubMed
  132. Song M, et al. 2013. Am J Pathol. 182:1308. PubMed
  133. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  134. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  135. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  136. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  137. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  138. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  139. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  140. Cheng HW, et al. 2022. Nat Commun. 13:2027. PubMed
  141. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  142. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  143. Mendelsohn AC, et al. 2020. Am J Physiol Cell Physiol. 319:C997. PubMed
  144. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  145. INAGAWA H, et al. 2016. In Vivo. 30: 205 - 211. PubMed
  146. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  147. Clemente C, et al. 2018. Nat Commun. 9:910. PubMed
  148. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  149. Li C, et al. 2018. Cell. 174:285. PubMed
  150. Nalbandian A, et al. 2017. Inflammation. 40:21:00. PubMed
  151. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  152. Fletcher P, et al. 2021. J Toxicol Environ Health A. 84:152. PubMed
  153. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  154. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  155. Yun H, et al. 2020. Immunity. 53(5):1050-1062.e5. PubMed
  156. Chan M, et al. 2013. J Cell Sci. 126:3948. PubMed
  157. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  158. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  159. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  160. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  161. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  162. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  163. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  164. Senatus L, et al. 2020. JCI Insight. 5:00. PubMed
  165. Urbanska AM, et al. 2020. Cancer Biother Radiopharm. 35:459. PubMed
  166. Frank AC, et al. 2019. Nat Commun. 10:1135. PubMed
  167. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  168. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  169. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  170. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  171. Zhang L, et al. 2021. Front Mol Biosci. 8:647647. PubMed
  172. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  173. Zhang L, et al. 2020. Cell. 442:181. PubMed
  174. Sangaletti S, et al. 2021. iScience. 24(6):102510. PubMed
  175. Sheng J, et al. 2021. eLife. 10:00. PubMed
  176. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  177. Kwon H, Kim S 2016. Cell Death Dis. 7:22285. PubMed
  178. Kong P, et al. 2013. Am J Physiol Heart Circ Physiol. 305:1363. PubMed
  179. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  180. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  181. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  182. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  183. Bajracharya B, et al. 2022. Biomed Res Int. 2022:9928362. PubMed
  184. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  185. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  186. Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed
  187. Li S, et al. 2017. Applied Materials & Interfaces. 10.1021/acsami.7b03160. PubMed
  188. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  189. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  190. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  191. Ramavath NN, et al. 2021. Front Immunol. 12:786680. PubMed
  192. Shue YT, et al. 2022. Nat Commun. 13:2690. PubMed
  193. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  194. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  195. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  196. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  197. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  198. Denis C, et al. 2014. Nucleic Acids Res. 42:7370. PubMed
  199. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  200. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  201. Youssif C, et al. 2018. EMBO Mol Med. 10:e8403. PubMed
  202. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  203. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  204. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  205. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  206. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
RRID
AB_893490 (BioLegend Cat. No. 123113)
AB_893478 (BioLegend Cat. No. 123114)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10/25/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Brilliant Violet 605™ anti-mouse F4/80

  • Purified anti-mouse F4/80

  • Biotin anti-mouse F4/80

  • FITC anti-mouse F4/80

  • PE anti-mouse F4/80

  • PE/Cyanine5 anti-mouse F4/80

  • PE/Cyanine7 anti-mouse F4/80

  • APC anti-mouse F4/80

  • APC/Cyanine7 anti-mouse F4/80

  • Alexa Fluor® 488 anti-mouse F4/80

  • Alexa Fluor® 647 anti-mouse F4/80

  • Pacific Blue™ anti-mouse F4/80

  • PerCP anti-mouse F4/80

  • PerCP/Cyanine5.5 anti-mouse F4/80

  • Alexa Fluor® 700 anti-mouse F4/80

  • Brilliant Violet 421™ anti-mouse F4/80

  • Brilliant Violet 510™ anti-mouse F4/80

  • Alexa Fluor® 594 anti-mouse F4/80

  • Brilliant Violet 785™ anti-mouse F4/80

  • Purified anti-mouse F4/80 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse F4/80

  • Brilliant Violet 650™ anti-mouse F4/80

  • Brilliant Violet 711™ anti-mouse F4/80

  • APC/Fire™ 750 anti-mouse F4/80

  • TotalSeq™-A0114 anti-mouse F4/80

  • TotalSeq™-B0114 anti-mouse F4/80

  • TotalSeq™-C0114 anti-mouse F4/80

  • Spark YG™ 570 anti-mouse F4/80

  • KIRAVIA Blue 520™ anti-mouse F4/80

  • Ultra-LEAF™ Purified anti-mouse F4/80

  • APC/Fire™ 810 anti-mouse F4/80

  • Spark NIR™ 685 anti-mouse F4/80
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account